Hugo Barbosa
Hugo Barbosa
EU Customer Omnichannel Director
ViiV Healhcare
Friday 24 May
Building Organizational Digital Fluency to Reshape Pharma Customer Engagement
As an industry our life before COVID-19 was easier! Our entire commercial model was based on the number of F2F calls we needed in order to maximize the value of each customer. But then... Suddenly, we saw ourselves in a situation where we could not engage physically with our customers and this brought digital to be a top priority.
In that sense, a new hybrid engagement model, that evolved during this period, blends both in-person and digital engagements!
Now, while no one knows exactly how the right blend looks like... one think seems to be clear: a trend for a personalized approach taking into account each individual customer, his digital and scientific profile, his preferences, his activity etc
However, personalization is a complex task, it takes deep knowledge of the customer, and perfect visibility to his entire experience.
It is such an amount of information that can´t simply be managed by a person or a team.
Because it has implications not only in technology but also in ways of working, Metrics, Leadership, Culture and Capabilities, successful omnichannel engagement, at scale, requires a certain level of Digital Fluency.
Bullet Points:
- Introduction
- Digital Fluency Concept
- Digital Fluency Dimensions
Digital Foundations
Digital operations
Digital leadership Culture
Workforce technology quotient
- Where are we as an industry
- Where to Focus Moving Forward
Hugo Barbosa
EU Customer Omnichannel Director
ViiV Healthcare
Friday 24 May
Panel Discussion: Master Pre & Early-Launch KOL Engagement Through Channel & Content Excellence
The pharmaceutical landscape is rapidly transforming, and it has become increasingly crucial for companies to adopt omnichannel marketing strategies while fostering early relationships with KOLs and DOLs. This expert panel discussion aims to delve into current industry trends, share effective strategies, and uncover ground-breaking solutions that can help you optimize omnichannel marketing efforts and cultivate influential KOL alliances to boost your pharmaceutical launches and market presence.
Panel Discussion Format:
The panel discussion will feature a moderator introducing the topic and guiding the conversation among panellists. Each panellist will share their expertise and experiences, followed by a Q&A session where attendees can ask questions and engage with the experts.
Key Talking Points:
- KOL Journey Mapping: How to identify critical touchpoints and create seamless, personalized experiences across channels
- Channel Integration and Consistency: Strategies for ensuring a unified brand presence and messaging across all platforms
- Data-Driven Personalization: Leveraging AI and analytics to tailor content and drive engagement
- KOL Identification and Engagement: Building meaningful relationships with influencers to enhance credibility and reach
- Content Strategy and Co-Creation: Developing valuable, engaging content in collaboration with KOLs
- Compliance and Regulatory Considerations: Navigating the complex landscape while executing impactful campaigns
- Performance Metrics and Measurement: Tracking success, optimizing strategies, and ensuring continuous improvement
Moderator:
Claude Waddington
MD & Principal Consultant Commercial Strategy
The Palindromic
Panelists
Hugo Barbosa
EU Customer Omnichannel Director
Viiv Healthcare
Christian Wöckel
Head of RSV Franchise @Vaccines Germany
Sanofi
Prasant Vijayakumar
Head of Content Strategy and Enablement
Viseven